INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 279 filers reported holding INTELLIA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.98 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $757,920 | -22.5% | 24,000 | 0.0% | 0.26% | -14.4% |
Q2 2023 | $977,760 | +9.4% | 24,000 | 0.0% | 0.30% | +19.7% |
Q1 2023 | $894,000 | +6.9% | 24,000 | 0.0% | 0.25% | -3.5% |
Q4 2022 | $836,640 | -37.7% | 24,000 | 0.0% | 0.26% | -40.1% |
Q3 2022 | $1,343,000 | -94.4% | 24,000 | +1832.4% | 0.43% | +72.4% |
Q2 2022 | $24,000,000 | +4596.7% | 1,242 | -94.8% | 0.25% | +117.4% |
Q1 2022 | $511,000 | -82.0% | 24,000 | 0.0% | 0.12% | -81.8% |
Q4 2021 | $2,836,000 | – | 24,000 | – | 0.63% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Discovery Value Fund | 561,561 | $17,756,559 | 9.73% |
MPM BioImpact LLC | 544,639 | $17,221,485 | 4.60% |
Casdin Capital, LLC | 1,178,075 | $37,250,732 | 4.12% |
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,145,091 | $36,207,777 | 3.72% |
Atlas Venture Associates IX, LLC | 10,000 | $316,200 | 2.69% |
Deep Track Capital, LP | 2,000,000 | $63,240,000 | 2.44% |
ARK Investment Management | 9,948,629 | $314,575,638 | 2.41% |
Merlin Capital, Inc | 18,526 | $585,792 | 2.19% |
Orchard Capital Management, LLC | 159,155 | $5,032,481 | 1.86% |
TANG CAPITAL MANAGEMENT LLC | 397,600 | $12,572,112 | 1.77% |